JH-TIE center director Jonathan Schneck discusses his group’s work on the development of a high-throughput system to analyze neoepitope-specific T-cell immune responses. Video produced by the National Cancer Institute.
Jonathan Schneck Featured in IMAT Video
In a paper published in the September issue of Nano Letters, Hickey, et al. reported a series of technologies that streamline enrichment, expansion, and detection of a wide range of antigen-specific T cells for cancer, infectious disease, and autoimmunity. The authors developed a concept of “adaptive artificial antigen presenting cells,” which can target an array of T cell specificities and are compatible with a 96-well plate format to facilitate high-throughput enrichment and expansion of rare,…
This press release is by Johns Hopkins Medicine and appeared in the Newsroom on November 13, 2019. If the saying that two heads are better than one is true, then joining two fields of science may be better than one to spur more advances in medicine. With a $6.7 million, five-year grant from the National Institutes of Health, Johns Hopkins Medicine researchers will bring together immunologists, oncologists and biomedical engineers in an effort to build new tools…